Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05413889 · ClinicalTrials.gov registry record · NA
Validation and Implementation Design of an Epic Systems 30-day Unplanned Readmission Risk Model
A NA study of Unplanned Hospital Readmissions and Patients at High Risk of Unplanned Readmission, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
- 1
- Study location
NCT05413889 is a NA study of Unplanned Hospital Readmissions and Patients at High Risk of Unplanned Readmission that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 68 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05413889, a NA study of Unplanned Hospital Readmissions and Patients at High Risk of Unplanned Readmission, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective is to assess the implementation of a computerized clinical decision support (cCDS) tool for identifying patients at high risk of unplanned readmission who could benefit from existing care programs aimed at reducing readmissions
Conditions Studied
Interventions
- BEHAVIORAL Epic 30-day unplanned readmission risk score
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2023-02-02 |
| Est. Completion | 2023-08-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05413889
The ClinicalTrials.gov registry entry for NCT05413889 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Unplanned Hospital Readmissions appearing as the primary indexed condition, and to 1 intervention - of which Epic 30-day unplanned readmission risk score is the first listed.
NCT05413889 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT05413889 about?
NCT05413889 is a clinical study titled "Validation and Implementation Design of an Epic Systems 30-day Unplanned Readmission Risk Model". The objective is to assess the implementation of a computerized clinical decision support (cCDS) tool for identifying patients at high risk of unplanned readmission who could benefit from existing care programs aimed at reducing readmissions
What is the current status of trial NCT05413889?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2023-02-02. Estimated completion is 2023-08-17.
What conditions does trial NCT05413889 study?
This clinical trial studies the following conditions: Unplanned Hospital Readmissions, Patients at High Risk of Unplanned Readmission.
What interventions are being tested in trial NCT05413889?
The interventions under investigation include: Epic 30-day unplanned readmission risk score (BEHAVIORAL).
Who is sponsoring clinical trial NCT05413889?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05413889 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Unplanned Hospital Readmissions
All registered trials for this condition
Patients at High Risk of Unplanned Readmission
All registered trials for this condition
North Carolina
All trials with a study site in North Carolina
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.